Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 907-728-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity: > 5000 mg/kg bw, based on read-across from Beta-pinene, which was tested in OECD TG 401.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Remarks:
- Beta-pinene
- Adequacy of study:
- key study
- Study period:
- The study was conducted in 1975.
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
- Justification for type of information:
- The information is used for read across to Rosemarel
- Reason / purpose for cross-reference:
- read-across: supporting information
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- no
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Ace Animals
- Weight at study initiation: 235-287 g
- Fasting period before study: 16-20 hours
- Housing: 5/cage in suspended wire mesh cages. Bedding was placed beneath the cages.
- Diet: fresh Purina Rat Chow (Diet #5012), ad libitum, except 16-20 hours prior to dosing
- Water: ad libitum
- Acclimation period: at least 1 week
ENVIRONMENTAL CONDITIONS
- Photoperiod (hrs dark / hrs light): 12 / 12 - Route of administration:
- oral: gavage
- Vehicle:
- unchanged (no vehicle)
- Details on oral exposure:
- Beta-pinene was administered by gavage at one dose of 5000 mg/kg bw.
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10 males/dose
- Control animals:
- no
- Details on study design:
- - Frequency of observations: Animals were observed 3-4 hours post dosing and once daily thereafter for 14 days for mortality, toxicity and pharmacological effects.
- Necropsy of survivors performed: yes
- Other examinations performed: mortality, toxicity and pharmacological effects. - Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- One rat died on day 7.
- Clinical signs:
- No symptoms observed.
- Body weight:
- No information provided.
- Gross pathology:
- No information provided.
- Other findings:
- No other findings were noted.
- Interpretation of results:
- other: Not classified
- Remarks:
- According to EU CLP 1272/2008 and its amendments.
- Conclusions:
- The acute oral LD50 for the substance in rats was determined to be greater than 5000 mg/kg bw.
- Executive summary:
Acute oral toxicity was performed with Beta-pinene similar to the guideline OECD TG 401. Ten male rats were used and they were administered the substance at the dose of 5000 mg/kg bw. One rat of ten died during the study on day 7. No symptoms in rats were observed. The acute oral LD50 for the substance in rats was determined to be greater than 5000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Information is based on read across
- Justification for type of information:
- The full read-across document can be found in the Endpoint Summary in text and in the attached file.
- Reason / purpose for cross-reference:
- read-across source
- GLP compliance:
- no
- Test type:
- other: read across information
- Key result
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other: Criteria for classification are not met
- Remarks:
- according to EU CLP (EC 1272/2008 and its amendments)
- Conclusions:
- Rosemarel has an LD50 > 5000 mg/kg bw based on read across from Beta-pinene which was tested in a study similar to OECD TG 401.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
The acute oral toxicity of Rosemarel was assessed using read across from Beta-pinene (CAS# 127-91-3). First the study with the analogue is described and thereafter the read across justification is presented.
Acute oral toxicity study with Beta-pinene:
Acute oral toxicity was performed with Beta-pinene similar to the guideline OECD TG 401, pre-GLP. Ten male rats were used and they were administered the substance at the dose of 5000 mg/kg bw. One rat of ten died during the study on day 7. No symptoms in rats were observed. The acute oral LD50 for the substance in rats was determined to be greater than 5000 mg/kg bw.
The acute oral toxicity of Rosemarel using read across from Beta-pinene (CAS#127-91-3)
Introduction and hypothesis for the analogue approach
Rosemarel is a multi-constituent. The major part is the constituent Beta-pinene (51%) and this constituent has a hexyl ring bridged with one carbon, to which two methyl groups are attached. At the alpha position there is a double bonded methyl group attached to the hexyl ring, which is the functional group. The minor constituent (36%) has the same backbone. The functional group is an epoxide in the place where there is the double bonded methyl group in the other component. For Rosemarel data on acute oral toxicity are lacking.
In accordance with Article 13 of REACH, lacking information should be generated whenever possible by means other than vertebrate animal tests, i. e. applying alternative methods such as in vitro tests, QSARs, grouping and read-across. For assessing the acute oral toxicity of Rosemarel the analogue approach is selected because for one closely related analogue acute oral toxicity information is available which can be used for read across.
Hypothesis: Rosemarel has similar acute oral toxicity compared to the Beta-pinene, resulting in a similar LD50. Although Beta-pinene as such presents a different reactivity than the epoxide constituent of Rosemarel, once systemically available, Beta-pinene will be partly oxidized to epoxide, so the target and source substances will be very similar and are predicted to have similar systemic toxicity.
Available information: The source chemical Beta-pinene has been tested in a an acute oral toxicity test with 10 rats (Moreno, 1975; similar to OECD TG 401, non-GLP) with one dose of 5000 mg/kg bw and the test result receives a reliability of 2.
Target chemical and source chemical(s)
The target is Rosemarel, and the source is Beta-pinene. Chemical structures of the target chemical and the source chemical are shown in the data matrix below. Also physico-chemical properties thought to be relevant for acute oral toxicity are listed in there.
Purity / Impurities
Rosemarel consists of Beta-pinene (51 %) and its oxidised form- the epoxide (36 %). The impurities are all below < 10%.
Analogue approach justification
According to Annex XI 1.5, read across can be used to replace testing when the similarity can be based on a common backbone and a common functional group. When using read across, the result derived should be applicable for C&L and/or risk assessment and it should be presented with adequate and reliable documentation.
Analogue selection:
Beta-pinene was selected as an analogue because it is Rosemarel’s major constituent, and when it is oxidised, Beta-pinene becomes Rosemarel’s minor constituent.
Structural similarities and differences:
Rosemarel contains 51% Beta-pinene and thus the overlap between the analogues is already 51%. The epoxide constituent has the same backbone as Beta-pinene but the double bond is oxidized into the epoxide component of Rosemarel.
Toxico-kinetic:
Absorption: Rosemarel’s constituents (Beta-pinene and Rosemarel’s epoxide) have similar absorption potential based on the fact of being liquids, on their low molecular weight (ca. 150) and on their physico-chemical properties that favour oral absorption (e.g. log Kow around 3.2 - 4.4).
Metabolisation: Beta-pinene will oxidize into the epoxide during the metabolisation and thereafter both constituents of Rosemarel will follow a similar pathway.
Fig. The sequence of Phase 1 metabolic steps for Rosemarel’s Beta-pinene (1ststructure), Rosemarel’s epoxide (2ndstructure) and the hydrolysed product (3rdstructure), which are possibly conjugated during Phase 2 metabolic pathways.
Uncertainty of the prediction:
There is no remaining uncertainty. First of all, Rosemarel contains 51% of Beta-pinene and secondly, Beta-pinene will oxidize to the epoxide during metabolization. This means that also for the epoxide constituent the LD50 > 5000 mg/kg bw can be anticipated.
Conclusions per endpoint for C&L and dose descriptor
When using read across the result derived should be applicable for C&L and/or risk assessment and be presented with adequate and reliable documentation.For Beta-pinene a well conducted acute oral toxicity test is available (Reliability2) with an LD50 > 5000 mg/kg bw. Based on these data for Beta-pinene, also for Rosemarel an LD50 > 5000 mg/kg bw can be derived.
Final conclusion on hazard and C&L: Rosemarel has an LD50 > 5000 mg/kg bw.
Data matrix: Information to support the read across for Rosemarel from Beta-pinene to assess the acute oral toxicity of Rosemarel.
Name of substance |
Rosemarel and its two constituents: Beta-pinene and its oxidation product |
Beta-pinene |
Chemical structure |
||
Empirical |
C10H16 and C10H16O |
C10H16 |
Cas No |
127-91-3 and 6931-54-0, respectively |
127-91-3 |
REACH registration |
To be registered for 2018 |
Registered (2010) |
EINECS |
- |
242-060-2 |
Mol weight |
136.24 and 152.24 |
136.24 |
Phys-chem |
|
|
Appearance |
Colourless to slight yellow liquid (IFF, 2016) |
Liquid |
Melting point(oC) |
<-20 (IFF, 2016) |
-20 (ECHA site) |
Boiling point (oC) |
173.85 (C) 172.2 (IFF, 2016) |
150.80 (C) 166-179 (ECHA site) |
Vapour pressure (Pa at 25oC) |
345.9 (IFF, 2016) |
851 (ECHA site) |
Water solubility (mg/l) |
7.1 and 338 (C) 45.7 (IFF, 2016) |
7.1 (C) 6.95 (ECHA site) |
Log Kow |
4.35 and 2.95 (C) 3.2-3.4 (IFF, 2016) |
4.35 (C) 4.4 (ECHA site) |
Human health |
|
|
Acute oral toxicity (mg/kg bw) |
Read across from Beta-pinene |
LD50 > 5000 |
C: calculated value, the physico-chemical data were generated with EPISuite (version 4.1).
Justification for classification or non-classification
The substance does not need to be classified for acute toxicity by the oral route, based on the EU CLP regulation (1272/2008) and its amendments.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.